Facephi Biometria, S.A. (ALPHI.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ALPHI.PA in your mock portfolio yet.
The extremely high PE ratio of 210 on a very small EPS base (0.01) suggests the stock is priced for aggressive future growth that is not yet visible in current earnings. Profitability appears thin, and any slowdown in growth or margin pressure could quickly make the valuation look stretched. Without evidence of rapidly scaling earnings, the risk/reward profile from a fundamentals standpoint leans unfavorable.
At €2.10, the stock trades below its 200-day moving average of €2.42, indicating a weak intermediate trend. The recent 5.4% decline over the last month reinforces a short-term downward bias. Combined with the elevated valuation, the technical setup currently points to downside or, at best, limited upside until momentum improves.
Alternative data show a mixed but generally stable picture. Website traffic of roughly 78,000 visitors per month and around 4,000 daily mobile app downloads point to meaningful user and partner engagement, which is constructive for a biometrics-focused business. Social media signals are mostly flat to modestly positive, suggesting steady brand presence but not a breakout in market interest.
Overall, the setup appears balanced to slightly cautious: operational and engagement indicators are reasonably healthy, but the stock trades at a very demanding valuation while technicals are weak. The market is clearly pricing in strong future growth, yet current earnings and recent price action do not fully confirm that trajectory. Until earnings scale more convincingly or technical momentum turns, the risk/reward profile looks neutral with a downside tilt.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started